IP Library › Granted Patent US 10,954,497
Granted Patent B2
US 10,954,497 · App. 15/766,894 · Granted Mar 23, 2021

Polypeptides

Inventors: Morten Gjermansen (Greve, DK); Klaus Gori (Copenhagen, DK); Henrik Marcus Geertz-Hansen (Copenhagen, DK); Jesper Salomon (Holte, DK); Thomas Holberg Blicher (Copenhagen, DK); Mary Ann Stringer (Soborg, DK); Nikolaj Spodsberg (Holte, DK); Tianqi Sun (Beijing, CN)
Assignee: NOVOZYMES A/S
C12N9/22C11D3/2065C11D3/22C11D3/3707C11D3/38627C11D3/38636C11D3/38681C11D11/0017C12Y301/21C12Y301/21001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,954,497
App. No.
15/766,894
Granted
Mar 23, 2021
Kind
B2
Abstract

The present invention relates to polypeptides, nucleotides encoding the polypeptide, as well as methods of producing the polypeptides. The present invention also relates to detergent composition comprising polypeptides, a laundering method and the use of polypeptides.

Claims (30)

1. A composition comprising

(a) at least 0.002 ppm of a polypeptide having DNase activity, wherein the polypeptide comprises the motif HXXP and has at least 95% sequence identity to the polypeptide shown in SEQ ID NO: 21,

(b) one or more polyol(s) selected from the group consisting of glycerol, (mono, di, or tri) propylene glycol, ethylene glycol, polyethylene glycol, sugar alcohols, sorbitol, mannitol, erythritol, dulcitol, inositol, xylitol and adonitol, and

(c) a surfactant,

wherein the composition is formulated as a bar, a homogenous tablet, and a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a liquid.

2. The composition of claim 1 , wherein the polypeptide having DNase activity has at least 97% sequence identity to the polypeptide shown in SEQ ID NO: 21.

3. The composition of claim 1 , wherein the polypeptide having DNase activity comprises the amino acid sequence of SEQ ID NO: 21.

4. The composition of claim 1 , wherein the polypeptide having DNase activity consists of the amino acid sequence of SEQ ID NO: 21.

5. The composition of claim 1 , wherein the polypeptide having DNase activity is a variant of the polypeptide of SEQ ID NO: 21, wherein the variant has DNase activity and comprises one or more amino acid substitutions, or one or more amino acid deletions, or one or more amino acid insertions or any combination thereof in 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 positions.

6. The composition of claim 1 , wherein the polypeptide having DNase activity comprises one or more of the motifs selected from the group consisting of

(SEQ ID NO 198)

[T/D/S][G/N]PQL,

(SEQ ID NO 199)

[G/T]Y[D/S][R/K/L],

(SEQ ID NO 200)

[E/D/H]H[I/V/L/F/M]X[P/A/S],

(SEQ ID NO: 201)

[F/L/Y/I]A[N/R]D[L/I/P/V]

and

(SEQ ID NO: 202)

C[D/N]T[A/R].

7. The composition of claim 1 , wherein the polypeptide having DNase activity comprises a GYS motif and one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 204) or ASXNRSKG (SEQ ID NO: 205).

8. The composition of claim 1 , further comprising a second enzyme.

9. The composition of claim 8 , wherein the second enzyme is a protease.

10. The composition of claim 8 , wherein the second enzyme is an amylase.

11. The composition of claim 8 , wherein the second enzyme is a lipase.

12. The composition of claim 1 , wherein the surfactant is an anionic or a nonionic surfactant.

13. The composition of claim 1 , further comprising a polymer.

14. The composition of claim 1 , wherein the composition is in the form of a granule comprising a core and a coating that has one or more layer(s) surrounding the core.

15. The composition of claim 1 , wherein the composition is in the form of a liquid.

Priority Claims (3)
DK PA 2015 00615 · Oct 7, 2015 · national
DK PA 2015 00617 · Oct 7, 2015 · national
DK PA 2015 00618 · Oct 7, 2015 · national
Continuity (1)
Related Publication 20200123476A1 · Apr 23, 2020
Cited By (2)
US 12,371,682 US 12,509,645